
Repurposing Medicines: When Old Drugs Find New Routes
Drug repurposing is reshaping medicine. Discover how changing a drug's route of administration — not the molecule itself — can unlock new therapeutic potential.
Showing results for: "drug repurposing" (41 results)

Drug repurposing is reshaping medicine. Discover how changing a drug's route of administration — not the molecule itself — can unlock new therapeutic potential.

Tuberculosis (TB) remains one of the world's deadliest infectious diseases, claiming over a million lives each year. TB is the deadliest infectious disease known today, claiming more lives than COVID-19. TB is caused by the bacterium Mycobacterium tuberculosis. TB spreads through the air when infected people breathe, cough, sneeze,

Natural polysaccharides like locust bean gum and chitosan are replacing lactose as safer, more effective carriers for inhaled medications and vaccines.

Why is mucus the biggest obstacle to lung drug delivery? Explore the mucosal barrier science reshaping how we design inhaled medicines and vaccines.

Discover how antigen-presenting cells like dendritic cells and macrophages are being recruited through smart particle design for vaccines and immunotherapy.

(DCTs) are redefining how pharmaceutical studies are designed, conducted, and analyzed by moving away from traditional site-centric models toward patient-centric, digitally enabled trial ecosystems.

Animal models have traditionally served as the cornerstone of drug safety evaluation; however, major translational challenges persist due to interspecies differences in physiology, metabolism, and genetic regulation. Many compounds demonstrating favorable toxicity profiles in animals later fail during human trials or are withdrawn post-marketing due to unforeseen adverse effects, especially hepatotoxicity and cardiotoxicity (Lee et al., 2025).

Smart nanoparticles are an exciting step forward in modern medicine especially nanomedicine. They help doctors be more precise in cancer treatment.

Vancomycin is an essential glycopeptide antibiotic used to treat life-threatening infections caused by Gram-positive bacteria, particularly Methicillin-Resistant Staphylococcus aureus (MRSA). It functions by inhibiting bacterial cell-wall synthesis and is still the most potent drug to be used when others fail (Patel, Preuss, & Bernice, 2023).

How a 150-year-old food industry technique became essential for creating stable biologics and inhaled medicines, transforming liquid drugs into life-saving powders.

Too big, it hits your throat. Too small, you exhale it. The sweet spot delivers drugs exactly where they're needed.

From innovative methods for cancer treatment to understanding the complexities of the human gut biome, these discoveries not only enhance our comprehension of the world but also lay the foundation for future groundbreaking advancements.

Nanotechnology is having a big impact on pharmaceutical sciences, and drug delivery systems are one area where this is most evident. Compared to conventional medication delivery methods, nanoparticles provide a number of benefits, including increased effectiveness and fewer adverse drug reactions.

Antibiotic resistance is making common infections hard to treat. Learn why it happens, how it affects communities in Nigeria and beyond, and what we can do to protect these life-saving medicines.

Healthcare is changing faster than ever before. Thanks to breakthroughs in artificial intelligence (AI), genomics, and wearable technology, medicine is entering the era of smart health, where data, devices, and biology work together to create care tailored to the individual.

Explore the multi-organ cellular mapping of GLP-1 receptor agonists. Discover how GLP-1RAs act as a systemic shield across T2DM, obesity, PMOS, MASH and so on.

Modern healthcare is undergoing a silent revolution. Now to treat a disease in the healthcare system, there is no longer a need to wait for symptoms to appear.

Inhaled antibiotics deliver drugs directly to lung infections, achieving better results with fewer side effects, which is a game-changer in fighting resistance.

Today, generalized anxiety disorder is affecting millions of Americans. The disorder usually traps the sufferers in cycles of fear and isolation in a way that even standard treatments cannot relieve completely. UCSF neuroscientist Jennifer Mitchell, PhD, is testing a surprising brand-new approach that can ease symptoms of generalized anxiety disorder by reshaping how the brain thinks and feels.

The current trajectory of epilepsy management has encountered a formidable "refractory wall." Despite the accelerated expansion of the neuropharmacological pharmacopeia,